RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

AstraZeneca Plc

A collection of news and information related to AstraZeneca Plc published by this site and its partners.

Top AstraZeneca Plc Articles

Displaying items 37-48
  • Horizon Pharma in deal to buy Ireland's Vidara for $660M

    Horizon Pharma in deal to buy Ireland's Vidara for $660M
    Deerfield-based Horizon Pharma Inc. said Wednesday it will move its headquarters to Ireland as part of a reverse merger with Dublin-based Vidara Therapeutics International Inc. valued at $660 million. The deal, which is expected to close mid-year, is...
  • Chronic illness education offered for patients, others in Newport News

    Chronic illness education offered for patients, others in Newport News
    Preventing and managing chronic diseases has taken center stage with local health systems trying to control costs and improve outcomes for patients. Bon Secours Mary Immaculate Hospital offers free diabetes management classes on the second and fourth...
  • Drug maker Merck laying off 8,500 in strategy overhaul

    Drug maker Merck laying off 8,500 in strategy overhaul
    Merck & Co., the second-largest drug maker by sales, said Tuesday it will lay off 8,500 employees in a strategy overhaul to revamp its research and development efforts.  That's on top of a previous announcement that the Whitehouse Station, N.J.-based...
  • FDA approves new diabetes medication

    FDA approves new diabetes medication
    The Food and Drug Administration on Wednesday approved U.S. marketing of the drug dapagliflozin, the second of a new class of medications that aim to improve glycemic control in patients with Type 2 diabetes. The drug will be marketed under the name...
  • FDA says new cholesterol drugs may not need outcome studies

    FDA says new cholesterol drugs may not need outcome studies
    Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
  • Big pharma: Few new antibiotics in the works

    Big pharma: Few new antibiotics in the works
    Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...
  • Dean's Guests for Breast Cancer 2012 - Links and Info

    Dean's Guests Include:         Medical Expert: Dr. Kathy Albain - Medical Oncologist (Specialty: Breast Cancer) - Loyola University Medical Center - Cardinal Bernardin Cancer Center Link to Dr. Albain's biographyWebsite Medical Expert: Dr. Claudia Perez -...
  • Inhaling steroids stunts growth, but not much

    Inhaling steroids stunts growth, but not much
    CHICAGO (Reuters) - Adults who took inhaled steroids as children to control their asthma may be shorter than they otherwise would have been, but only by a little, U.S. researchers said on Monday. Results of a long-term asthma study found that children...
  • Propofol, the drug that killed Michael Jackson, isn't 'dangerous'

     
    In this week’s coverage of the trial of Michael Jackson’s personal physician, Dr. Conrad Murray, articles have been consistent in describing the drug that killed the pop star: Tuesday: “the dangerous surgical anesthetic propofol”...
  • Pharma cases drive U.S. Attorney's collections

     
    The U.S. Attorney’s Office for the Eastern District of Pennsylvania announced Thursday that it has collected nearly $4.4 billion in civil penalties since 2004. While the rules for disbursing those payments between state and federal agencies make it...
  • AstraZeneca to pay $68.5 million in Seroquel settlement

     
    California Atty. Gen. Kamala D. Harris on Thursday announced a $68.5-million multistate settlement with AstraZeneca Pharmaceuticals after the states sued the company for allegedly using unfair and deceptive marketing practices for its antipsychotic drug...
  • Party time again: Michelle Obama explains the Angela Merkel state dinner for you guys without invites

     
    Germany's leader is feted at the Obamas' fourth White House State Dinner. With full guest list....